Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BioCryst Pharmaceuticals Inc. June 12, 202485.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,500 | — | — |
| Dec 13, 2024 | BioCryst Pharmaceuticals Inc. | Open-market sale | −7,000 | $7.54 | $52,780 |
| Jun 12, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +6,820 | — | — |
| May 20, 2024 | BioCryst Pharmaceuticals Inc. | Open-market purchase | +5,000 | $6.38 | $31,900 |
| Jun 14, 2023 | BioCryst Pharmaceuticals Inc. | Open-market sale | −12,866 | $8.04 | $103,443 |
| Jun 13, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +16,745 | — | — |
Questions about Nancy J. Hutson
What boards is Nancy J. Hutson on?
Nancy J. Hutson sits on the board of BioCryst Pharmaceuticals Inc.
How long has Nancy J. Hutson served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.